Blinatumomab superior to chemotherapy for refractory ALLMarch 1, 2017Leukemia, Myelodysplasia, Transplantation
Vaccine + chemo induce robust T-cell responses in late-stage cervical cancerMarch 1, 2017Gynecologic CancerImmuno-oncology
Chemo gives no boost to ADT for patients with localized prostate cancerMarch 1, 2017Genitourinary Cancer
‘Strong evidence’ links obesity to cancersFebruary 28, 2017Gynecologic CancerGastroenterologyLymphoma & Plasma Cell DisordersBreast CancerGastrointestinal Cancer
Genomic differences seen in mRCC during first- and second-line therapyFebruary 28, 2017Genitourinary CancerRenal Cell CarcinomaImmuno-oncology
Proportion of rectal cancer in young adults doublesFebruary 28, 2017GastroenterologyGastrointestinal Cancer
Immune recovery may predict survival in myeloma patients with stem cell transplantsFebruary 25, 2017Lymphoma & Plasma Cell Disorders
Older AML patients benefit from frailty assessment and interventionsFebruary 25, 2017Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Phase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Preventive CareLymphoma & Plasma Cell Disorders
Guidelines tackle long-term screening, management of myelomaFebruary 25, 2017Rare DiseasesLymphoma & Plasma Cell Disorders
Fewer post-transplant CMV infections with novel antiviral prophylaxisFebruary 24, 2017Patient & Survivor Care
